Company profile for Laxxon Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Laxxon is a cutting-edge pharma-technology company leading the development of advanced pharmaceuticals through its pioneering SPID® platform technology, based on novel 3D screen printing. This innovative approach not only enhances drug delivery capabilities for both existing pharmaceuticals and new developments but also facilitates rapid market access and offers extensive IP protection. Laxxon's diverse product pipeline inclu...
Laxxon is a cutting-edge pharma-technology company leading the development of advanced pharmaceuticals through its pioneering SPID® platform technology, based on novel 3D screen printing. This innovative approach not only enhances drug delivery capabilities for both existing pharmaceuticals and new developments but also facilitates rapid market access and offers extensive IP protection. Laxxon's diverse product pipeline includes 13 in-house Advanced Patented Generics, alongside ongoing collaborations with prominent pharmaceutical firms, biotech organizations, and research universities.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
261 Madison Ave, New York, NY 10016, United States
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251027435719/en/Laxxon-Medical-to-Attend-BIO-Europe-and-Jefferies-Healthcare-Conference-World-Premier-Life-Science-Partnering-Events

BUSINESSWIRE
27 Oct 2025

https://www.businesswire.com/news/home/20250811941253/en/Laxxon-Medical-Announces-Successful-Product-Development-Milestone-with-Novel-Oral-Modified-Release-Formulation-of-Verus-Enobosarm-Utilizing-Laxxons-SPID-Technology

BUSINESSWIRE
11 Aug 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/laxxon-medical-announces-positive-pilot-pk-study-results-for-advanced-979196

ACCESSWIRE
04 Feb 2025

https://www.accesswire.com/968778/laxxon-medical-announces-positive-pilot-pk-study-results-in-pigs-for-groundbreaking-oral-glp-1-dosage-form

ACCESSWIRE
15 Jan 2025

https://www.accesswire.com/965826/laxxon-medical-announces-appointment-of-two-new-members-to-board-of-directors

ACCESSWIRE
09 Jan 2025

https://www.accesswire.com/965029/laxxon-medical-to-participate-in-27th-annual-needham-growth-conference

ACCESSWIRE
07 Jan 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty